Not exact matches
As a cancer researcher, do you think the mechanisms of
tumor growth are somehow changing to come into line with your perceptions, or is it possible that the process of our learning more about DNA mutations and
cell architecture and nutrient exchange and epigenetic effects make it possible for us to inch ever closer to understanding that which is already going
on under our noses?
Investigators focused
on the
tumor suppressor liver kinase B1 (LKB1), a protein that controls
cell growth and metabolism.
A study analyzing brain
tumor genomics
on a single -
cell level has found evidence that cancer stem
cells fuel the
growth of oligodendrogliomas, a slow - growing but incurable form of brain cancer.
Patients received a tandem of lenalidomide, a drug that kills
tumor cells, blocks blood vessel
growth, and acts
on the immune system, and dexamethasone, an anti-inflammatory agent, plus one of three new agents:
In this study, we found that chloroquine not only has an effect
on the
growth of the cancer
cells, but also makes the
tumor environment less aggressive by normalizing the abnormal blood vessels in the
tumor,» says Patrizia Agostinis.
«In drug development, it's easier to turn that
growth function off than it is to switch
on the
cell's defective
tumor suppression mechanism.»
Inhibition of transcription (blockade of water)
on tumor suppressor genes, such as p21, leads to
cell transformation (
growth of the cactus - like eremophytes instead of normal plants from the drought).
About 20 percent of breast cancer patients have overexpressed
growth receptors, known as Her2 + receptors,
on the cancer
cells, which cause uncontrolled
tumor growth.
On the safety side, the panelists delved into the possible risks of injecting genetically modified
cells into patients, including the potential for deadly viral infections, brain toxicity, and, paradoxically, the
growth of new
tumors brought about by CAR - T
cells years after treatment.
Josef Singer and Judith Fazekas, both lead authors of the study, discovered that a receptor frequently found
on human
tumor cells (epidermal
growth factor receptor or EGFR) is nearly 100 percent identical with the EGF receptor in dogs.
Since cancer
cells bear very specific antigens
on the surface, the corresponding antibodies bind to these molecules and thus inhibit
tumor growth.
«We're looking for multiple mutations across
tumors, mutations that turn
on genes and promote
cell growth,» Dias - Santagata says.
Understanding this in stem
cells could further understanding
on how these proteins are involved in
tumor growth.
«Our experiments showed that restoring H19 expression hindered by too much p53 restored «protective differentiation» of osteoblasts to counter events of
tumor growth early
on in bone cancer,» said co-author, Ihor Lemischka, PhD, Director of The Black Family Stem
Cell Institute within the Icahn School of Medicine.
Highly dependent
on their estrogen receptors for
growth and survival, these
tumor cells are sensitive to hormonal therapies, making drugs like tamoxifen and fulvestrant effective first - line therapies for many patients.
LA JOLLA, CA — A tightly controlled system of checks and balances ensures that a powerful
tumor suppressor called p53 keeps a tight lid
on unchecked
cell growth but doesn't wreak havoc...
LA JOLLA, CA — A tightly controlled system of checks and balances ensures that a powerful
tumor suppressor called p53 keeps a tight lid
on unchecked
cell growth but doesn't wreak havoc in healthy
cells.
A reverse situation can also happen; sometimes genes can be abnormally turned
on by epigenetics, causing uncontrollable
cell growth and the appearance of a
tumor.
Injections of iPSC - EPCs did not however have significant effect
on tumor growth or
on overall survival, but transducing
cells with a baculovirus expressing CD40L, a member of the TNF gene family which can induce apoptosis [6, 7], and injection into the breast cancer lung metastasis, increased levels of pro-apoptotic cytokines in lung tissues, indicating the induction of apoptosis by CD40L carried by the EPCs (See figure).
Runaway
cell proliferation is driven by accelerators, or oncogenes, that are stuck
on go — in collusion with broken brakes, or
tumor suppressors, that can't control a
tumor's pedal - to - the - metal
growth.
To explore the biological function of DDX3
on cell growth control, a colony formation assay was done in several
tumor cell lines (HuH - 7, HCT116, and HeLa) and normal murine fibroblast
cells (NIH 3T3) under the selection of G418.
The glands lining the inner wall of the colon are the sites for most abnormal
cell behavior such as uncontrolled
cell growth, which results in polyps (non-cancerous
growths) and later
on in adenocarcinomas or
tumors.
We also found that the EphB4 receptor expressed
on the surface of breast cancer
cells can promote
tumor xenograft
growth by enhancing blood vessel formation through interactions with its preferred ligand, ephrin - B2, present in
tumor endothelial
cells.
Harold Varmus: Well the simplistic way to think about that is and I'm not sure this is the way it will be worked out, is to be able to take just a few
cells from those early lesions and examine them genetically or for other kinds of marks
on the DNA that would predict whether or not this is some - this is a lesion which might or an early stage
growth that might never be able to progress, but it is also possible that every early
tumor of that kind has some probability of expanding and invading and growing to become a medical problem, so getting that right will obviously be crucial because it's very difficult to say when you've diagnosed something that is an early stage
tumor that it won't progress.
Hunter's breakthrough, which set the story in motion, was a product of basic research
on a chicken RNA
tumor virus: the 1979 discovery of the first tyrosine kinase paved the way for our understanding of how
cells perceive their environment and respond appropriately to
growth signals.
The proliferation rates of the cancer in the flax - eaters were only half that of the controls, confirming the test - tube studies done
on prostate cancer
cells suggesting that flax can indeed slow prostate
tumor growth.
Polyunsaturated fats such as corn oil and soybean oil are highly unstable and vulnerable to oxidation — and oxidation, in turn, is linked to cancer — while the omega - 6 fatty acids that predominate in vegetable oils have been shown to accelerate the
growth of
tumor cells.6 As Fallon and Enig explain, 4 excessive consumption of toxic polyunsaturated oils — not red meat — represents a known mechanism for colon cancer: «Colon cancer occurs when high levels of dietary vegetable oils and hydrogenated fats, along with certain carcinogens, are acted
on by certain enzymes in the
cells lining the colon, leading to
tumor formation» [Emphasis added].
According to Lise Alschuler, author of the Definitive Guide To Cancer: An Integrative Approach to Prevention, Treatment, and Healing, studies
on flax lignans demonstrate safety and efficacy in their use against breast cancer, «inhibiting the
growth of human estrogen - dependent breast cancer
cells in mice and strengthening the
tumor - inhibitory effect of tamoxifen».
Cinnamon's effect
on cancer
cells and
tumor growth has so far only been studied in animals, but was found to be toxic to cancer
cells and to cause cancer
cell death.
Skin
Tumors: These tumors are a result of abnormal cell growth on a dog's
Tumors: These
tumors are a result of abnormal cell growth on a dog's
tumors are a result of abnormal
cell growth on a dog's skin.
Once they occur, mast
cell tumors can quickly grow from small «skin tag» - like
growths on the surface to the skin to invading full thickness of the skin, and progressing to the lymph nodes for systemic infection.
Most mast
cell tumors are found
on the skin and may be detected by a sudden swelling or
growth.
So far this year, American Veterinarian ® has reported
on immunotherapies that may slow
growth or even shrink gliomas in dogs and humans, a liquid biopsy assessment tool to detect
tumor cell mutation, and a shared study between the American Kennel Club Canine Health Foundation and the V Foundation for Cancer Research
on the treatment of bladder cancer.